A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy

Rheumatology (Oxford). 2020 Apr 1;59(4):905-907. doi: 10.1093/rheumatology/kez444.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Anemia
  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Antibodies, Antinuclear / immunology
  • Arthralgia / drug therapy
  • Arthralgia / genetics
  • Arthralgia / immunology
  • Blood Sedimentation
  • Bronchiectasis / diagnosis
  • Bronchiectasis / drug therapy
  • Bronchiectasis / genetics
  • Bronchiectasis / immunology
  • C-Reactive Protein / immunology
  • Child, Preschool
  • Cough
  • Failure to Thrive
  • Female
  • Fever / drug therapy
  • Fever / genetics
  • Fever / immunology
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Immunoglobulin G / immunology
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Interferon Type I
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / genetics
  • Lung Diseases, Interstitial / immunology
  • Membrane Proteins / genetics*
  • Multiple Pulmonary Nodules / diagnosis
  • Multiple Pulmonary Nodules / drug therapy
  • Multiple Pulmonary Nodules / genetics
  • Multiple Pulmonary Nodules / immunology
  • Osteoarthropathy, Primary Hypertrophic
  • Sequence Analysis, DNA
  • Serum Amyloid A Protein
  • Skin Diseases, Vascular / diagnosis*
  • Skin Diseases, Vascular / drug therapy
  • Skin Diseases, Vascular / genetics
  • Skin Diseases, Vascular / immunology
  • Vascular Diseases / diagnosis*
  • Vascular Diseases / drug therapy
  • Vascular Diseases / genetics
  • Vascular Diseases / immunology

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Antinuclear
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Interferon Type I
  • Membrane Proteins
  • STING1 protein, human
  • Serum Amyloid A Protein
  • C-Reactive Protein